Sanofi Shares Drop to €72.78, a New Low Since the Covid Crash
Sanofi shares fell by 0.92% to €73.06 in mid-afternoon trading. During the session, the stock touched €72.78, a new low since the 2020 Covid-19 crash (previous record was €72.83). Meanwhile, the CAC 40 was down 0.73% at 8,142.46 points.
A New Six-Year Low Following a Difficult Week
The pharmaceutical company has had a challenging week, with a decline of 8.47% over seven days and a drop of 9.08% over three months. Over the past year, the stock has lost 20.3%, marking one of the most significant underperformances in the European health sector. Falling below €73 erases all the gains seen after the first quarter results were published. To recall, the Q1 2026 results announced on April 23 were strong, with a revenue increase of 13.6% at constant exchange rates and a 14% rise in earnings per share from operations. The stock's momentum shifted after a downgrade by Morgan Stanley on May 4, followed by a new six-year low of €74.21 during the session on May 5. Today's movement extends this pressure.
Below the Lower Bollinger Band, RSI at 30
The stock is trading at €73.06, below the lower Bollinger Band set at €74.32. This configuration, coupled with an RSI that has dropped to 30, indicates seller exhaustion in a continuous downtrend since mid-April. The 50-day moving average, at €79.26, and the 200-day moving average, at €82.20, are now 8.5% and 12.5% above the current price, respectively, illustrating a clear break with the trend of recent months. One-month volatility has risen to 7.19. The technical threshold of €73.74, which served as support the previous day, has just given way. The next points of reference are today's historic low of €72.78 on one side, and the resistance at €82.87 on the other. On the agenda, the next financial milestones are the second quarter 2026 results, scheduled for July 30.
